iCare® Home vs Goldmann Applanation Tonometry

Sponsor
St. Erik Eye Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT04911387
Collaborator
(none)
61
1
7
8.7

Study Details

Study Description

Brief Summary

Self-tonometry with iCare Home is regularly performed at Sankt Erik's Eye Hospital since a few years back. The purpose of this study was to show that the eye pressure measurements made with iCare® Home by patients / relatives do not vary more than those made with the standard method, Goldman applanation tonometry (GAT), by different healthcare professionals. This will hopefully confirm the usefulness of self-tonometry.

Condition or Disease Intervention/Treatment Phase
  • Device: Intraocular pressure measurments

Detailed Description

Since a few years back, self-tonometry with iCare® Home has been available in glaucoma care. Sankt Erik's Eye Hospital was first in Sweden to use the new technology. Several studies have shown good agreement between measurements made by patients or healthcare professionals with iCare® Home and Goldman applanation tonometry (GAT). However, some researchers raise critical voices about the reliability of iCare® Home measurements because they can differ from GAT. GAT is considered the gold standard method of tonometry to which all other instruments are compared. But like all other methods, GAT has some limitations.

At the clinic, the eye pressure is usually measured with GAT by different staff (ophthalmological nurses, opticians or doctors) from visit to visit. This can sometimes lead to pressure variations that may affect the follow-up of glaucoma patients. This raises the question of whether the difference between GAT and iCare® Home is statistically and clinically significant.

The purpose of this study was to show that the eye pressure measurements made with iCare® Home by patients / relatives do not vary more than those made with the standard method GAT by different healthcare professionals. This will hopefully confirm the usefulness of self-tonometry.

Study Design

Study Type:
Observational
Actual Enrollment :
61 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
iCare® Home vs Goldmann Applanation Tonometry: Agreement of the Methods and Comparison of Inter-observer Variation at a Tertiary Eye Centre
Actual Study Start Date :
Apr 1, 2020
Actual Primary Completion Date :
Oct 31, 2020
Actual Study Completion Date :
Oct 31, 2020

Outcome Measures

Primary Outcome Measures

  1. Correlation between iCare® Home inter-user measurements [12 months]

    iCare® Home measurements made by participants (patients and volunteers) will be compared to iCare® Home measurements made by trainers' using the same device on the same occasion

  2. Correlation between GAT measurements made by different healthcare personnel [12 months]

    GAT measurements made by iCare® Home trainers will be compared to GAT measurements made by other available healthcare personnel using a different device on the same occasion

Secondary Outcome Measures

  1. Agreement between iCare® Home tonometry and GAT [12 months]

    Agreement, repeatability and reliability of measurements made with iCare® Home tonometry and GAT will be assessed using Bland Altman analysis, ANOVA and interclass correlation coefficient (ICC).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • primary open angle glaucoma (POAG)

  • pseudo-exfoliation glaucoma (PEX)

  • ocular hypertension (OHT)

  • no eye disease,

Exclusion Criteria:
  • inability to perform measurements due to limited hand or arm mobility (eg rheumatism, tremor)

  • measurements outside the iCare® Home manufacturer's recommendations.

Contacts and Locations

Locations

Site City State Country Postal Code
1 St Erik Eye Hospital Stockholm Sweden 11282

Sponsors and Collaborators

  • St. Erik Eye Hospital

Investigators

  • Principal Investigator: Enping Chen, MD Ph D, St. Erik Eye Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Enping Chen, MD Ph D, St. Erik Eye Hospital
ClinicalTrials.gov Identifier:
NCT04911387
Other Study ID Numbers:
  • iCare Home vs GAT
First Posted:
Jun 3, 2021
Last Update Posted:
Jun 3, 2021
Last Verified:
May 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Enping Chen, MD Ph D, St. Erik Eye Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 3, 2021